Balchem Corporation (BCPC): Price and Financial Metrics
Balchem Corporation (BCPC)
Today's Latest Price: $103.36 USD
Updated Dec 2 4:00pm
Add BCPC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BCPC Stock Summary
- Balchem Corp's stock had its IPO on June 3, 1986, making it an older stock than 92.73% of US equities in our set.
- Price to trailing twelve month operating cash flow for BCPC is currently 24.93, higher than 82.21% of US stocks with positive operating cash flow.
- The volatility of Balchem Corp's share price is greater than that of just 1.3% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Balchem Corp are FDS, MGRC, SAIA, DOOR, and LOPE.
- Visit BCPC's SEC page to see the company's official filings. To visit the company's web site, go to www.balchem.com.
BCPC Stock Price Chart Interactive Chart >
BCPC Price/Volume Stats
| Current price | $103.36 | 52-week high | $113.93 |
| Prev. close | $104.43 | 52-week low | $78.30 |
| Day low | $102.89 | Volume | 91,900 |
| Day high | $104.77 | Avg. volume | 136,861 |
| 50-day MA | $102.03 | Dividend yield | 0.5% |
| 200-day MA | $97.33 | Market Cap | 3.34B |
Balchem Corporation (BCPC) Company Bio
Balchem Corporation consists of four business segments: ARC Specialty Products, SensoryEffects (formerly Food, Pharma and Nutrition), Animal Nutrition & Health, and Industrial Products. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The company was founded in 1967 and is based in New Hampton, New York.
BCPC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $103.36 | $38.15 | -63% |
Below please find a table outlining a discounted cash flow forecast for BCPC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Balchem Corp ranked in the 25th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 63.17%. As for the metrics that stood out in our discounted cash flow analysis of Balchem Corp, consider:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 94. Its equity weight surpasses that of 87.44% of free cash flow generating stocks in the Basic Materials sector.
- The business' balance sheet reveals debt to be 6% of the company's capital (with equity being the remaining amount). Approximately merely 16.54% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- BCPC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 42.42% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -64% |
| 1% | -64% |
| 2% | -63% |
| 3% | -63% |
| 4% | -63% |
| 5% | -62% |
For other companies in the Basic Materials that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as BCPC, try OR, TECK, CDE, MAS, and SYNL.
Loading social stream, please wait...